7-OH Ban — What You Need to Know

01 — The Filing

What they actually filed

On July 1, 2026, the DEA issued two Notices of Intent to begin temporary (emergency) scheduling. One targets 7-OH above a set concentration threshold — the government's own words say this is aimed at concentrated and synthetic 7-OH, allowing the trace amounts of 7-OH that occur naturally in kratom leaf products to remain outside the scheduling action. The other Notice of Intent outright schedules three lab-made derivatives — MP, MGM-15, and MGM-16 — that do not occur in the plant at all. HHS and FDA publicly commended the move the same day.

We believe enhanced kratom alkaloid products should have sensible regulations rather than an outright ban: rigorous lab testing, educational materials packaged with every product, child-proof containers, a 21-and-up purchase age, removal from gas stations and stores that don't check ID at the door, removal from stores that sell alcohol, mandatory age verification on websites, regulated and consistent product naming, and a ban on advertising these products online or otherwise — since ads for enhanced alkaloid products can reach vulnerable populations and youth.

Not targeted

The natural leaf

Whole-leaf kratom (Mitragyna speciosa) contains only trace 7-OH. The filing says it is not meant to capture the botanical leaf.

Targeted

Concentrated & synthetic 7-OH

High-concentration 7-OH above a threshold, plus lab-made derivatives MP, MGM-15 and MGM-16 — sold as tablets, gummies, and shots.

DEA press release headline: DEA to Temporarily Schedule 7-OH and Related Substances to Protect Public Safety, dated July 1, 2026 — **DEA — Notice of Intent.** "DEA to Temporarily Schedule 7-OH and Related Substances." Filed July 1, 2026.
dea.gov ↗

HHS press release headline: HHS, FDA Commend DEA Action Against Dangerous Enhanced 7-OH Products, dated July 1, 2026 — **HHS / FDA — Statement.** "HHS, FDA Commend DEA Action Against Enhanced 7-OH Products." July 1, 2026.
hhs.gov ↗

02 — The Record

How we got here

Every entry links to a primary source. This didn't come out of nowhere — it was a year in the making.

July 29, 2025

FDA & HHS recommend Schedule I for 7-OH

At a joint press conference, FDA recommends scheduling 7-OH and releases a report. The Commissioner calls concentrated 7-OH a possible "fourth wave" of the opioid epidemic.

fda.gov ↗

June – Dec 2025

Warning letters & a seizure

FDA sends warning letters to seven companies selling 7-OH products, dated June 25 and announced July 15. In December, FDA, DOJ and the U.S. Marshals seize roughly $1M of 7-OH product from three firms in Missouri.

hhs.gov ↗

Oct 2025 – Mar 2026

Congressional pressure

Senators and House members send letters urging the DEA to move fast on emergency scheduling, repeating the "13× morphine" and "fourth wave" framing.

marshall.senate.gov ↗ · bresnahan.house.gov ↗

July 1, 2026 — Today

DEA files two Notices of Intent

The emergency scheduling process officially begins. A public comment window (an OASH Request for Information on the threshold) opens alongside it.

hhs.gov ↗

03 — The Mechanism

How DEA emergency scheduling works

Two tracks exist. The DEA chose the fast one.

Under 21 U.S.C. § 811(h), the DEA can temporarily place a substance in Schedule I to address an "imminent hazard." A notice must run at least 30 days before an order can issue, and a temporary order lasts up to two years. The slower permanent path — the full eight-factor analysis, formal notice-and-comment, and judicial review — is a separate process the agency can pursue later.

STEP 01

Notice of Intent

DEA publishes its intent to schedule and the grounds for it.

Published 7/1/26

STEP 02

Comment window

HHS/OASH's request-for-information docket (HHS-OASH-2026-0232) on the concentration threshold.

Open since 7/6/26

STEP 03

Review

Comment window closes; comments go to the Secretary for HHS for consideration by the Attorney General.

Closes 7/31/26

STEP 04

Temporary order

A Schedule I order may issue some unknown amount of time after the comment window closes — this timing can't be predicted.

Timing unknown

04 — The Scrutiny

The questions the record doesn't answer

This is where the story is. Not a conspiracy — a process that may not have met its own standard. Every point below is sourced.

The emergency track is meant for a genuine "imminent hazard," and past emergency actions rested on patterns of deaths, seizures, and law-enforcement data. Independent legal analysis of the 7-OH action notes a thinner record: no confirmed fatalities from 7-OH alone, about 53 poison-control calls over a three-month period, and little seizure or trafficking data — with the case leaning heavily on animal studies and receptor-binding data rather than real-world harm.

It skips the full analysis

Emergency scheduling lets the DEA act without completing the eight-factor analysis, and such orders are generally not subject to judicial review.

Even allies asked for the receipts

A supportive industry group (AHPA) publicly urged FDA to release its eight-factor analysis in the name of "radical transparency." Has it been released?

THE OPEN QUESTION: Did the government meet its own emergency standard, and will it show its work? Every point above is sourced to the public record.

Source: legal analysis of the evidence base ↗

The medicine they're scheduling → The data: where's the wave? → Who benefits from the crackdown? → How does 7-OH compare? → Share these materials →

05 — Your Move

The public comment window is already open

It closes July 31, 2026. This is the single highest-leverage thing you can do — but not yet, and not without reading this first.

WHY WE'RE NOT SAYING "GO COMMENT RIGHT NOW": the docket (HHS-OASH-2026-0232) solicits input specifically on the concentration threshold for 7-OH — not a general up-or-down vote on whether kratom should be legal. A comment that just says "don't ban kratom" is answering a question the docket didn't ask, and may not carry the weight a comment addressing the actual threshold would. We'd rather everyone understand the ask and coordinate around consistent messaging than have thousands of off-target comments go in before people know what's actually being requested.

WAIT FOR THE WEBINAR: 7-HOPE Alliance is holding a webinar to walk people through writing an effective, on-target comment for this specific docket. We recommend holding off on submitting until after it, so your comment benefits from that guidance instead of guessing at the format. Register for the webinar →

Quality beats quantity — this is not a numbers contest. In federal rulemaking, a hundred copy-pasted identical comments get bundled and counted as basically one. A single specific, personal, substantive comment on the actual question asked carries real weight. And the math that actually moves the needle is simple:

Great comment

Person you bring

2×

Your impact

Write one meaningful comment. Then get one other person to write theirs. That's worth more than you leaving a hundred. Here's a framework that keeps a comment specific enough to count — write it in your own words, never copy-paste:

Who you are

A real person, in a real place. "I'm a [job] in [state]." No form-letter openings.

Your specific experience

Concrete and yours — what changed, over what timeframe. Specifics are what reviewers can't dismiss.

Speak to the threshold

The docket is specifically about the concentration threshold. If you have data or a view on where that line should sit, say so — this is the question actually being asked.

The process point

Ask the government to show its work: the full evidence and analysis behind an emergency finding.

Be civil and clear

Comments become public record. No personal info you don't want public. Respectful and specific always outperforms angry and vague.

View the docket at Regulations.gov →

NOTE: Docket HHS-OASH-2026-0232, "Temporary Placement of 7-Hydroxymitragynine Above a Specified Threshold in Schedule I; Request for Information," posted July 6, 2026. Comments close July 31, 2026.

06 — The Playbook

This was beaten before — in 2016

The last time the DEA tried this, the public won. Here's exactly how.

On August 31, 2016, the DEA filed to place kratom's alkaloids into Schedule I — effectively banning the plant — and it did so without a public comment period. The response was fast, organized, and bipartisan. Six weeks later, the DEA blinked.

Petition signatures

House members — bipartisan

Notice → withdrawal

Aug 31, 2016

DEA files to schedule kratom

A Notice of Intent to place mitragynine and 7-OH into Schedule I — bypassing public comment.

dea.gov ↗ · federalregister.gov ↗

September 2016

The counter-offensive

A White House petition passed 142,000 signatures. Roughly 400 people rallied at the White House. A bipartisan letter from 51 House members — 28 Democrats, 23 Republicans — called the move "hasty" and demanded a comment period.

prnewswire.com ↗

Oct 13, 2016

DEA withdraws — and opens comment

Citing the volume of public input, the DEA withdrew its notice and opened a formal comment period. By 2018, HHS had pulled its scheduling request entirely.

federalregister.gov ↗ · forbes.com ↗

THE LESSON: It was won on the process argument and a bipartisan coalition — 23 Republicans signed that letter. This isn't a left-or-right fight; it's a "did the government follow its own rules" fight. Framed that way, it wins. Framed as one party's cause, it shrinks.

07 — The Action Stack

What to do now

In order. Notice that "submit a comment" isn't step one — understanding the ask is.

Understand the scope first

The docket is scoped to the concentration threshold specifically — not a general vote on kratom. Read the framework above before you write anything.

Hold off filing today

Register for 7-HOPE Alliance's webinar on writing an effective comment, and wait until after it to submit. A wave of aligned, on-topic comments outweighs a wave of scattered ones.

Prepare your comment now

Draft it in your own words using the framework above, so you're ready to file the moment coordinated guidance drops.

Recruit one person

Walk one other person through preparing theirs too. One good comment plus one recruit beats a hundred of your own.

Plan wisely

If you use 7-OH, get on stable footing now rather than at a deadline. See the support section below.

08 — Work Together

Plug into the groups already fighting

You don't have to build this alone. These organizations are already producing advocacy materials and collecting testimony — the highest-leverage move is to use what they publish, share it, and add your story.

Grassroots advocacy

HAVEN Access

Runs an action hub, a media toolkit, a "reach out to the DEA" guide, and a story collector. Share their materials and submit your testimony.

havenaccess.org ↗

501(c)(3) nonprofit

7-HOPE Alliance

Federal and state action pages, an education hub on 7-OH, and the #WeAreAllKratom testimony drive. Add your story and amplify the campaign.

7hopealliance.org ↗

Advocacy organization

HART — Holistic Alternative Recovery Trust

Advocacy and support organization focused on the recovery and consumer-safety side of the enhanced-alkaloid conversation. Share their materials and add your story.

hartsupporter.com ↗

COORDINATE, DON'T DUPLICATE: When these groups put out a plan or materials, get behind their plan rather than splintering. Shared toolkits, one message, many voices.

09 — Take Care of Yourself

If you use 7-OH, plan wisely

Whatever happens with the ruling, being on stable footing protects you. This is support, not a schedule.

Don't stop abruptly if you're dependent

7-OH acts on opioid receptors, and stopping suddenly can be rough. If you're physically dependent, gradual reduction with guidance from a clinician is the safer path — not a hard stop timed to a deadline.

Plan now, not at the deadline

Getting to a stable, lower baseline early means a possible supply disruption doesn't catch you off guard. Steady footing now is the goal.

Talk to someone who can help

A doctor or addiction-medicine provider can tailor a safe plan and discuss options. Medication-assisted approaches exist and work for many people.

1-800-662-4357

SAMHSA National Helpline — free, confidential, 24/7, in English & Spanish. Treatment referrals and information.

10 — Together

Fear doesn't move the needle. People do.

Uncertain moments are exactly when a community proves what it's made of.

Nobody gets through this alone, and nobody has to. Check on each other. Share what you learn. Help someone file their comment, walk a friend through a plan, answer the person who's scared and doesn't know where to start. The 2016 win wasn't one hero — it was thousands of ordinary people who refused to sit quiet and moved together.

Panic scatters. Organization compounds. Don't give up, and don't go quiet — find your people, pick one thing from the action stack, and do it today. Then bring someone with you.